Latest News

  • QuantuMDx Tackles Infectious Diseases, High Prices With Molecular Diagnostic Kit

    Diagnostics World News | With current technologies in molecular diagnostics being too expensive, time-consuming, and lacking the ability to conduct multiple tests with a single sample, QuantuMDx is pushing its portable molecular diagnostic kit, called Q-POC, that analyzes samples at the point-of-care and provides results within 30 minutes.

    Apr 25, 2019
  • Teasing Apart Hope From Hype For Liquid Biopsy

    Diagnostics World News | Liquid biopsies are emerging as rapid and cost-effective tools for the management of cancer patients, making it difficult to sniff out hope from hype.

    Apr 24, 2019
  • Predicting Immunotherapy Response And Toxicity In Melanoma

    Diagnostics World News | There is an urgent need to identify biomarkers that accurately predict for treatment response and guide the selection of novel combination therapies for patients who acquire resistance.

    Apr 23, 2019
  • Digital Pathology Making Inroads Around The World

    Diagnostics World News | Pathologists around the world over—65,000 of them in 163 countries at last count—appear enamored of a free and easy-to-use digital pathology platform that allows slides to be aggregated irrespective of the scanner that created them.

    Apr 18, 2019
  • Young Scientists Present Diagnostic Solutions At Molecular Medicine Tri-Conference

    Diagnostics World News | During the Molecular Medicine Tri-Conference, dozens of early-career scientists presented their solutions to real-world clinical, scientific, and organizational problems at the event's poster viewing sessions.

    Apr 10, 2019
  • Point-Of-Care Testing And Diagnostics In Vietnam

    Diagnostics World News | At the Molecular Medicine Tri-Conference in San Francisco, Gerald Kost gave insight into point-of-care testing's impact in Central Vietnam.

    Apr 9, 2019
  • Variant Interpretation Then And Now: Moving Toward Rigorous, Consistent Workflows

    Diagnostics World Contributed Commentary | Variant interpretation has come a long way since the days when single-gene or even single-variant tests represented the cutting edge in clinical labs. With the explosion of next-generation sequencing (NGS) and other multiplex-friendly technologies, variant analysts who could once easily perform manual review of every mutation, now face an onslaught of data.

    Apr 5, 2019
  • ASHG Issues Position Statement On Recontact For Genetic Results

    Diagnostics World News Brief | The American Society of Human Genetics, along with several co-signing organizations, issued a position statement today outlining whether, and to what extent, there is a responsibility to recontact genetic and genomic research participants.

    Apr 4, 2019
  • Bill Gates, Jeff Bezos Donate Millions To Alzheimer's Research

    Diagnostics World News Brief | The Bill and Melinda Gates Foundation and the Day One Fund, launched by Amazon CEO Jeff Bezos, have teamed up to donate $15 million to the Alzheimer's Drug Discovery Foundation (ADDF) in support of its Diagnostics Accelerator research program. This latest donation brings the total program funding to $50 million since its launch in July 2018.

    Apr 3, 2019
  • From Nobel Prize-Worthy To Quaint: PCR’s Past, Present, And Predicted Future

    Diagnostics World News | Imagine a future in which polymerase chain reaction (PCR) is viewed as old-fashioned. In the meantime, researchers generate billions of copies of the sequence of interest in order to carry out experiments and procedures in fields like molecular biology, evolutionary biology, and medical diagnostics.

    Apr 3, 2019
  • MinION Could Reduce Huntington's Disease Diagnosis To Days Instead Of Weeks

    Diagnostics World News Brief | The world's first genetic test for Huntington's disease using nanopore-based DNA sequencing technology is now available at Guy's and St Thomas' NHS Foundation Trust.

    Apr 2, 2019